FDA Approves Regorafenib (Stivarga) for GIST

Published February 27, 2013

FDA Approves Regorafenib (Stivarga) for GIST

Filed under: drug addiction treatment center

“Stivarga is the third drug approved by the FDA to treat gastrointestinal stromal tumors,” said Richard Pazdur, MD, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, in a press release.
Read more on Cancer Network

Biotech Drugs Still Won't Copy

Filed under: drug addiction treatment center

Several high-profile projects to create so-called biosimilar drugs have faltered in recent months. Merck & Co. dissolved a dedicated biosimilar unit last year and in December retreated from a plan to copy arthritis treatment Enbrel after maker Amgen …
Read more on Wall Street Journal

Fertility drugs recalled from Waltham pharmacy

Filed under: drug addiction treatment center

State health officials have been conducting surprise inspections of compounders after a fungal meningitis outbreak was linked to Framingham-based New England Compounding Center last fall. … The two types of medications recalled by the company are …
Read more on Boston Globe